Analgesics in Canada is expected to register slower value expansion in 2026 than global averages, with performance primarily supported by price increases rather than volume gains, reflecting the impact of an ageing population and a subdued economic environment. The landscape is marked by major ownership changes, with the forthcoming integration of Tylenol and Motrin under Kimberly-Clark set to challenge established investment and distribution strategies at a time when consumer demand is shifting towards safer, localised pain relief solutions for older adults. Evolving purchasing patterns are reshaping the retail environment, as incremental growth in retail e-commerce and digital delivery erode the dominance of traditional pharmacy channels, which is prompting both manufacturers and retailers to accelerate portfolio rationalisation, channel innovation and omnichannel engagement. Brands seeking sustained growth must align closely with demographic trends, invest in differentiated formats such as topicals and adapt to a more fragmented retail environment through strategic partnerships and agile channel management.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in Canada with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Canada, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in Canada report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in Canada?
- Which are the leading brands in Analgesics in Canada?
- How are products distributed in Analgesics in Canada?
- How has the regulatory and operating environment for Analgesics changed in Canada?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Key Data Insights
Key Industry Trends
Portfolio simplification reshapes brand power and investment
Ageing population drives demand for topical formats
Pharmacy channel adapts to digital pressure
Chart 1 Value Sales 2021-2031
Chart 2 Value Sales by Category 2026
Topical investment set to widen the growth gap with oral formats
Ownership transition expected to raise pressure on Tylenol and Motrin
Digital convenience to reshape analgesics distribution
Chart 1 Forecast Value Sales 2021-2031
Chart 2 Forecast Value Sales by Category 2026-2031
Haleon consolidates its lead as concentration remains high
Brand investment and innovation sharpen competition
Kenvue acquisition introduces new competitive uncertainty
Chart 1 Company Shares 2026
Chart 2 Brand Shares 2026
Pharmacies retain leadership despite pressure on store-based retail
E-commerce and delivery partnerships expand online access
Chart 1 Retail Channels 2021-2026
Demographic shift and digital purchasing steer innovation
Format expansion and portfolio focus lead recent innovation
Topical resilience and portfolio discipline shape the business impact
Chart 1 Real GDP Growth 2021-2031
Chart 2 Inflation 2021-2031
Chart 1 Population 2021-2031
Chart 2 Population by Generation 2026
Chart 3 Consumer Expenditure 2021-2031
Country Reports Disclaimer
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!